AIM: Analyse the impact of aggressive surgical treatment with accurate lymphadenectomy in
medullary thyroid carcinoma. MATERIALS AND METHODS: We retrospectively analysed …

AIM: The analysis of a 37-year retrospective study on diagnosis, prognostic variables,
treatment and outcome of a large group of medullary thyroid cancer (MTC) patients was …

Background Medullary thyroid cancer (MTC) is rare, with poorer outcomes than
differentiated thyroid cancer. We aimed to identify areas for improvement in the pre …

Background: The purpose of this investigation was to analyze the individual diagnostic and
operative strategy in the treatment of medullary thyroid carcinoma (MTC) in international …

Background: Surgery is currently the only curative treatment for medullary thyroid cancer.
Unfortunately, the surgical strategy that will offer patients at each disease stage the best …

Background The extension of the compartment‐oriented neck dissection at primary surgery
in medullary thyroid carcinoma (MTC) is controversial. Because a< 50% decrease in …

Context: Total thyroidectomy with central lymph node dissection is recommended in patients
with medullary thyroid cancer (MTC). However, the relationship between disease severity …

BACKGROUND: The optimal initial operative management of medullary thyroid cancer
(MTC) and the use of biomarkers to guide the extent of operation remain controversial. We …

Background The relationship between extent of cervical lymphadenectomy along with the
number of involved lymph nodes (LNs) removed and overall survival has not been well …

BACKGROUND Medullary thyroid carcinoma is a rare tumour derived from the thyroid
parafollicular calcitonin‐secreting cells. Calcitonin is a very specific marker of this cancer …